Escientia Advanced Sciences Private Limited
Founded: 2013
Status: Active
Designation: Director
DR
Dwarakanath Srinivas Rachmadagu - Profile
Dwarakanath Srinivas Rachmadagu with 6 companies in General Business across 1 industry.
About
Dwarakanath Srinivas Rachmadagu
Dwarakanath Srinivas Rachmadagu has 10 years in corporate governance. Formerly with 6 companies, such as Escientia Advanced Sciences Private Limited and Escientia Biopharma Private Limited. Engaged in General Business. Contributes to corporate operations.
Current Companies
-
Past Companies
6
Total Affiliations
6
Oldest Company Age
-
Companies Associated with Dwarakanath Srinivas Rachmadagu
Current Companies
No current companies available.
Previous Companies
Escientia Biopharma Private Limited
Founded: 2008
Status: Active
Designation: Director
Syngenta India Private Limited
Founded: 2000
Status: Active
Designation: Additional Director
Syngenta India Private Limited
Founded: 2000
Status: Active
Designation: Whole-Time Director
Escientia Advanced Sciences Private Limited
Founded: 2013
Status: Active
Designation: Additional Director
Escientia Biopharma Private Limited
Founded: 2008
Status: Active
Designation: Additional Director
Explore Director's current and past company associations— Uncover their professional journey today!
Frequently Asked Questions
Who is Dwarakanath Srinivas Rachmadagu?
Dwarakanath Srinivas Rachmadagu has 10 years in corporate governance. Formerly with 6 companies, such as Escientia Advanced Sciences Private Limited and Escientia Biopharma Private Limited. Engaged in General Business. Contributes to corporate operations.
What is Dwarakanath Srinivas Rachmadagu's role in current companies?
Dwarakanath Srinivas Rachmadagu is associated with 0 companies as a director.
What industries does Dwarakanath Srinivas Rachmadagu specialize in?
Dwarakanath Srinivas Rachmadagu has expertise in General Business.
How many years of experience does Dwarakanath Srinivas Rachmadagu have?
Dwarakanath Srinivas Rachmadagu has 10 years in corporate governance.